Relay Therapeutics, Inc. (RLAY) revenue

Revenue · fiscal 2025
$15.36M

Relay Therapeutics, Inc. (RLAY) reported revenue of $15.36M in fiscal 2025 (the year ended December 31, 2025). That is 53.4% higher than the $10.01M of fiscal 2024. Figures as of 18 Nov 2026, 10:52 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$15.36M
Change on fiscal 2024
+53.4%
Growth, 5 years
−28.6% a year
Highest on record
$82.65Mfiscal 2020
Lowest on record
$1.38Mfiscal 2022
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Relay Therapeutics, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue shrank at a compound 28.6% a year. Across the 6 fiscal years on record (2020–2025), the highest was $82.65M in fiscal 2020 and the lowest $1.38M in fiscal 2022.

History · 6 fiscal years

Revenue by fiscal year

Relay Therapeutics, Inc. revenue, year by year

Relay Therapeutics, Inc. (RLAY) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$15.36M 53.4% up
2024$10.01M 60.8% down
2023$25.55M 1,749.8% up
2022$1.38M 54.4% down
2021$3.03M 96.3% down
2020$82.65M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on RLAY

Relay Therapeutics, Inc., figure by figure

Relay Therapeutics, Inc. (RLAY) overview: price, valuation and scorecard

Relay Therapeutics, Inc. revenue: questions and answers

What is Relay Therapeutics, Inc.'s revenue?

Relay Therapeutics, Inc. (RLAY) reported revenue of $15.36M in fiscal 2025 (the year ended December 31, 2025). That is 53.4% higher than the $10.01M of fiscal 2024.

What is the growth rate of Relay Therapeutics, Inc.'s revenue?

Over the five fiscal years to 2025 revenue shrank at a compound 28.6% a year.

What are the highest and lowest revenue figures on record for Relay Therapeutics, Inc.?

Across the 6 fiscal years on record (2020–2025), the highest was $82.65M in fiscal 2020 and the lowest $1.38M in fiscal 2022.

How is Relay Therapeutics, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Relay Therapeutics, Inc. it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Relay Therapeutics, Inc. (RLAY) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/RLAY/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.